No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs558275057 |
chr4:120552852-120552853 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs571796601 |
chr4:120552854-120552855 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs541642291 |
chr4:120552933-120552934 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs368277865 |
chr4:120552938-120552939 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs191842971 |
chr4:120553036-120553037 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs371020318 |
chr4:120553050-120553051 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs530285923 |
chr4:120553075-120553076 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs144047028 |
chr4:120553092-120553093 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs372541147 |
chr4:120553158-120553159 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs185029366 |
chr4:120553182-120553183 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs556090900 |
chr4:120553240-120553241 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs375406192 |
chr4:120553242-120553243 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs377511204 |
chr4:120553243-120553244 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs10010114 |
chr4:120553244-120553245 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs57666356 |
chr4:120553245-120553246 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs201260324 |
chr4:120553246-120553247 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs201886046 |
chr4:120553250-120553251 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs560948034 |
chr4:120553254-120553255 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs532553990 |
chr4:120553263-120553264 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs55777923 |
chr4:120553264-120553265 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
mRNA abundance
|
21 |
rs9998390 |
chr4:120553281-120553282 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs9998391 |
chr4:120553283-120553284 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs9998243 |
chr4:120553290-120553291 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs112170831 |
chr4:120553351-120553352 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs528581996 |
chr4:120553404-120553405 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs34835603 |
chr4:120553428-120553429 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
27 |
rs567372677 |
chr4:120553455-120553456 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs533400297 |
chr4:120553469-120553470 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs536415056 |
chr4:120553482-120553483 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs549819544 |
chr4:120553549-120553550 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs536904840 |
chr4:120553566-120553567 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs569608996 |
chr4:120553569-120553570 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs540509496 |
chr4:120553580-120553581 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs553402206 |
chr4:120553607-120553608 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs111998906 |
chr4:120553678-120553679 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs386678972 |
chr4:120553682-120553683 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs113866947 |
chr4:120553683-120553684 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs111954047 |
chr4:120553684-120553685 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs182189650 |
chr4:120553695-120553696 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs554613862 |
chr4:120553697-120553698 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs372838840 |
chr4:120553727-120553728 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs58710238 |
chr4:120553732-120553733 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs543949124 |
chr4:120553763-120553764 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs115034061 |
chr4:120553765-120553766 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs185136220 |
chr4:120553787-120553788 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs112567513 |
chr4:120553814-120553815 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs140140529 |
chr4:120553869-120553870 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs528460466 |
chr4:120553870-120553871 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs28866816 |
chr4:120553935-120553936 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
50 |
rs562174027 |
chr4:120553996-120553997 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|